MDOAX
Price
$9.81
Change
+$0.07 (+0.72%)
Updated
Jan 17 closing price
Net Assets
30.53M
RNWEX
Price
$77.31
Change
+$0.35 (+0.45%)
Updated
Jan 17 closing price
Net Assets
62.57B
Ad is loading...

MDOAX vs RNWEX

Header iconMDOAX vs RNWEX Comparison
Open Charts MDOAX vs RNWEXBanner chart's image
Morgan Stanley Developing Opportunity A
Price$9.81
Change+$0.07 (+0.72%)
VolumeN/A
Net Assets30.53M
American Funds New World R4
Price$77.31
Change+$0.35 (+0.45%)
VolumeN/A
Net Assets62.57B
MDOAX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDOAX vs. RNWEX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDOAX is a StrongBuy and RNWEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 62.6B vs. MDOAX (30.5M). RNWEX pays higher dividends than MDOAX: RNWEX (1.24) vs MDOAX (0.00). MDOAX was incepted earlier than RNWEX: MDOAX (5 years) vs RNWEX (22 years). RNWEX is a more actively managed with annual turnover of: 32.00 vs. MDOAX (15.00). RNWEX has a lower initial minimum investment than MDOAX: RNWEX (250) vs MDOAX (1000). MDOAX annual gain was more profitable for investors over the last year : 21.32 vs. RNWEX (7.10).
MDOAXRNWEXMDOAX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD-1.0091.072-94%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets30.5M62.6B0%
Annual Yield % from dividends0.001.24-
Returns for 1 year21.327.10300%
Returns for 3 years-8.87-3.47256%
Returns for 5 yearsN/A10.11-
Returns for 10 yearsN/A48.80-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STRO2.010.16
+8.65%
Sutro Biopharma
ACM108.931.08
+1.00%
Aecom
BANF119.750.95
+0.80%
BancFirst Corp
TSBX0.44-0.02
-4.75%
Turnstone Biologics Corp
CRMD12.17-0.62
-4.85%
CorMedix